Literature DB >> 6750017

Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells.

I I Sussman, J H Rand.   

Abstract

The presence of FVIII/VWF in human aortic subendothelium has been previously established. The present study was undertaken to determine the origin of this FVIII/VWF. Indirect immunofluorescence microscopy was employed to detect FVIII/VWF in rabbit aortas, after passage of a balloon catheter. Immediately after this de-endothelialization, FVIII/VWF was found to be present directly luminal to the internal elastic lamina. However, in the subsequent 5 days to 2 months, no FVIII/VWF was found on the luminal surface of exposed, nonre-endothelialized neointima. After endothelial cell regrowth, however, FVIII/VWF was again seen on the luminal surface. Thus these studies reveal that the deposition of subendothelial FVIII/VWF in neointima requires the presence of endothelial cells and that relatively trivial amounts of plasmatic FVIII/VWF are deposited on neointimal connective tissue after de-endothelialization.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6750017

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium.

Authors:  X X Wu; R E Gordon; R W Glanville; H J Kuo; R R Uson; J H Rand
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

2.  150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.

Authors:  J H Rand; N D Patel; E Schwartz; S L Zhou; B J Potter
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 3.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

4.  von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells.

Authors:  Mafalda Lopes da Silva; Daniel F Cutler
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

5.  Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree.

Authors:  J Gebrane-Younès; L Drouet; J P Caen; L Orcel
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

6.  Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium.

Authors:  J H Rand; X X Wu; B J Potter; R R Uson; R E Gordon
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

7.  Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.

Authors:  J J Sixma; K S Sakariassen; H V Stel; W P Houdijk; D W In der Maur; R J Hamer; P G de Groot; J A van Mourik
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Increased platelet deposition on atherosclerotic coronary arteries.

Authors:  G H van Zanten; S de Graaf; P J Slootweg; H F Heijnen; T M Connolly; P G de Groot; J J Sixma
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Injury induces increase of von Willebrand factor in rat endothelial cells.

Authors:  M A Reidy; M Chopek; S Chao; T McDonald; S M Schwartz
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

10.  Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets.

Authors:  P G de Groot; J H Reinders; J J Sixma
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.